Analystreport

IDI, Inc. (NASDAQ: COGT) is now covered by analysts at Roth Capital. They set a "buy" rating and a $7.65 price target on the stock.

Cogent Biosciences, Inc.  (COGT) 
Last cogent biosciences, inc. earnings: 11/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.cogint.com/investor-relations